FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945346075> ?p ?o ?g. }

• W2945346075 endingPage "3561" @default.
• W2945346075 startingPage "3552" @default.
• W2945346075 abstract "Breast cancer vaccines composed of antigens identified by serological analysis of cDNA expression libraries (SEREX) induce antigen specific immune responses in patients but have had disappointing clinical benefits. While many attempts to modify the adjuvants and vaccine method have been tried, one issue not addressed was whether the SEREX tumor-associated antigens identified from late stages of disease were ideal targets. We questioned in the transgenic TgMMTV-neu mouse model whether the antigen repertoire is distinct between early and late stage breast cancer and whether the antigens identified via SEREX from transgenic mice with early or late stage tumors would elicit differential anti-tumor effects to address this question. Three early stage antigens, Pdhx, Stk39, and Otud6B, were identified from a SEREX screen of mice prior to development of palpable lesions. Formulated into a vaccine, each early antigen inhibited tumor growth (p < 0.0001). The antigens identified from mice with late stage tumors (Swap70, Gsn, and Arhgef2) were unable to inhibit tumor growth when used as vaccines (for example Gsn p = 0.26). Each of the three early stage antigens were essential for tumor survival in syngeneic mouse tumor cells and in human breast cancer cell lines across breast cancer subtypes. Silencing protein expression of the early antigens increased apoptosis (p < 0.0001 for all antigens in mouse and p < 0.05 for all antigens in human triple negative breast cancer) and decreased survival (p < 0.0001 for all antigens in mouse and human triple negative and HER2 positive breast cancer). Overexpression of the early stage antigens in women with breast cancer predicted worse prognosis (p = 0.03) while overexpression of late stage antigens did not impact prognosis (p = 0.09). These data suggest that antigens expressed earlier in breast tumor development and functionally relevant to breast tumor growth may be more effective targets for therapeutic breast cancer vaccines than antigens identified in later disease." @default.
• W2945346075 created "2019-05-29" @default.
• W2945346075 creator A5021384712 @default.
• W2945346075 creator A5025625281 @default.
• W2945346075 creator A5031952463 @default.
• W2945346075 creator A5060432567 @default.
• W2945346075 creator A5068576259 @default.
• W2945346075 date "2019-06-01" @default.
• W2945346075 modified "2023-09-26" @default.
• W2945346075 title "Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets" @default.
• W2945346075 cites W1488880613 @default.
• W2945346075 cites W1806981800 @default.
• W2945346075 cites W1908864745 @default.
• W2945346075 cites W1978451385 @default.
• W2945346075 cites W1989238195 @default.
• W2945346075 cites W1990864165 @default.
• W2945346075 cites W1991253843 @default.
• W2945346075 cites W1994993231 @default.
• W2945346075 cites W2005768770 @default.
• W2945346075 cites W2016981231 @default.
• W2945346075 cites W2030123475 @default.
• W2945346075 cites W2038632547 @default.
• W2945346075 cites W2040352400 @default.
• W2945346075 cites W2044702943 @default.
• W2945346075 cites W2052766938 @default.
• W2945346075 cites W2059357604 @default.
• W2945346075 cites W2059920458 @default.
• W2945346075 cites W2062249523 @default.
• W2945346075 cites W2063384194 @default.
• W2945346075 cites W2077219444 @default.
• W2945346075 cites W2092180337 @default.
• W2945346075 cites W2096283457 @default.
• W2945346075 cites W2103210701 @default.
• W2945346075 cites W2103961035 @default.
• W2945346075 cites W2111449140 @default.
• W2945346075 cites W2112995207 @default.
• W2945346075 cites W2114843025 @default.
• W2945346075 cites W2117692326 @default.
• W2945346075 cites W2119584041 @default.
• W2945346075 cites W2137158234 @default.
• W2945346075 cites W2143450041 @default.
• W2945346075 cites W2144092647 @default.
• W2945346075 cites W2149441684 @default.
• W2945346075 cites W2150847030 @default.
• W2945346075 cites W2154620203 @default.
• W2945346075 cites W2157939496 @default.
• W2945346075 cites W2159365185 @default.
• W2945346075 cites W2162807881 @default.
• W2945346075 cites W2167648705 @default.
• W2945346075 cites W2170628193 @default.
• W2945346075 cites W2536678061 @default.
• W2945346075 cites W2556750995 @default.
• W2945346075 cites W2560367415 @default.
• W2945346075 cites W2586862255 @default.
• W2945346075 cites W2607450268 @default.
• W2945346075 cites W2663748508 @default.
• W2945346075 cites W2765241896 @default.
• W2945346075 cites W2883593119 @default.
• W2945346075 doi "https://doi.org/10.1016/j.vaccine.2019.05.024" @default.
• W2945346075 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7087478" @default.
• W2945346075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31126858" @default.
• W2945346075 hasPublicationYear "2019" @default.
• W2945346075 type Work @default.
• W2945346075 sameAs 2945346075 @default.
• W2945346075 citedByCount "12" @default.
• W2945346075 countsByYear W29453460752019 @default.
• W2945346075 countsByYear W29453460752020 @default.
• W2945346075 countsByYear W29453460752021 @default.
• W2945346075 countsByYear W29453460752022 @default.
• W2945346075 countsByYear W29453460752023 @default.
• W2945346075 crossrefType "journal-article" @default.
• W2945346075 hasAuthorship W2945346075A5021384712 @default.
• W2945346075 hasAuthorship W2945346075A5025625281 @default.
• W2945346075 hasAuthorship W2945346075A5031952463 @default.
• W2945346075 hasAuthorship W2945346075A5060432567 @default.
• W2945346075 hasAuthorship W2945346075A5068576259 @default.
• W2945346075 hasBestOaLocation W29453460751 @default.
• W2945346075 hasConcept C121608353 @default.
• W2945346075 hasConcept C147483822 @default.
• W2945346075 hasConcept C203014093 @default.
• W2945346075 hasConcept C2522874641 @default.
• W2945346075 hasConcept C2777701055 @default.
• W2945346075 hasConcept C2778378633 @default.
• W2945346075 hasConcept C2779777497 @default.
• W2945346075 hasConcept C502942594 @default.
• W2945346075 hasConcept C530470458 @default.
• W2945346075 hasConcept C54355233 @default.
• W2945346075 hasConcept C71924100 @default.
• W2945346075 hasConcept C86803240 @default.
• W2945346075 hasConcept C8891405 @default.
• W2945346075 hasConceptScore W2945346075C121608353 @default.
• W2945346075 hasConceptScore W2945346075C147483822 @default.
• W2945346075 hasConceptScore W2945346075C203014093 @default.
• W2945346075 hasConceptScore W2945346075C2522874641 @default.
• W2945346075 hasConceptScore W2945346075C2777701055 @default.
• W2945346075 hasConceptScore W2945346075C2778378633 @default.
• W2945346075 hasConceptScore W2945346075C2779777497 @default.
• W2945346075 hasConceptScore W2945346075C502942594 @default.

• next